NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free IBB Stock Alerts $132.59 -0.69 (-0.52%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$132.15▼$133.4150-Day Range$124.64▼$139.8152-Week Range$111.83▼$141.16Volume1.26 million shsAverage Volume1.79 million shsMarket Capitalization$7.33 billionAssets Under Management$7.08 billionDividend Yield0.30%Net Expense Ratio0.44% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial Media Get iShares Biotechnology ETF alerts: Email Address About iShares Biotechnology ETF (NASDAQ:IBB)iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More IBB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBB ETF News HeadlinesMay 2, 2024 | investing.comRisk On, Risk Off, or Risk Who Knows?May 1, 2024 | investing.comWhen Silver Looks Bad, It’s Usually a Sign of a BottomMay 8, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 30, 2024 | markets.businessinsider.comApril Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy MarketApril 28, 2024 | nasdaq.comJune 7th Options Now Available For iShares Trust - iShares Biotechnology ETF (IBB)April 19, 2024 | msn.com9 Best Biotech ETFs for 2024April 17, 2024 | nasdaq.comIBB Crosses Critical Technical IndicatorApril 10, 2024 | msn.comTop 10 best performing S&P 500 health care stocks of 2024May 8, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 8, 2024 | investing.comSemiconductors Steady, Biotech Stumbles: What's Next for These Sectors?See More Headlines Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings223 Fund Statistics Assets Under Management$7.08 billion Average Daily Volume$1.72 million Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume2,237 Put Options1,227 Call Options1,010 Short Interest8,740,000 shs Miscellaneous Outstanding Shares55,250,000Beta0.84 Creation Unit50,000 Creation Fee$614.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.44%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.44%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.44%0.60%0.60%0.54%0.58% iShares Biotechnology ETF (IBB) Holdings & ExposureTop 10 IBB HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 8.62%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.22%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 8.06%Gilead Sciences(NASDAQ:GILD)Holding Weight: 7.68%Moderna(NASDAQ:MRNA)Holding Weight: 4.34%IQVIA(NYSE:IQV)Holding Weight: 4.11%Biogen(NASDAQ:BIIB)Holding Weight: 3.18%Mettler-Toledo International(NYSE:MTD)Holding Weight: 2.73%argenx(NASDAQ:ARGX)Holding Weight: 2.04%Illumina(NASDAQ:ILMN)Holding Weight: 2.02%IBB Sector ExposureIBB Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D.Independent Chairman of the Board of TrusteesMichael Arthur LathamPresident, TrusteeJack GeeChief Financial Officer, TreasurerGeoffrey D. FlynnChief Operating Officer, Executive Vice PresidentBio & Compensation - Amy SchioldagerExecutive Vice PresidentIra P. ShapiroVice President, Chief Legal OfficerMatt TuckerVice PresidentBio & Compensation - Eilleen M. ClavereSecretaryCecilia H. HerbertIndependent TrusteeCharles A. HurtyIndependent TrusteeMore ExecutivesSimilar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipWilliams Jones Wealth Management LLC.Sold 11,073 shares on 5/8/2024Ownership: 0.108%SP Asset Management LLCSold 280 shares on 5/8/2024Ownership: 0.101%US Bancorp DESold 543 shares on 5/8/2024Ownership: 0.027%Baltimore Washington Financial Advisors Inc.Sold 611 shares on 5/8/2024Ownership: 0.013%Avantax Advisory Services Inc.Bought 1,466 shares on 5/8/2024Ownership: 0.010%View All Institutional Transactions IBB ETF - Frequently Asked Questions How have IBB shares performed in 2024? iShares Biotechnology ETF's stock was trading at $135.85 at the start of the year. Since then, IBB shares have decreased by 2.4% and is now trading at $132.59. View the best growth stocks for 2024 here. How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF? iShares Biotechnology ETF announced a quarterly dividend on Wednesday, March 20th. Stockholders of record on Friday, March 22nd will be paid a dividend of $0.126 per share on Wednesday, March 27th. This represents a $0.50 annualized dividend and a yield of 0.38%. The ex-dividend date of this dividend is Thursday, March 21st. Read our dividend analysis for IBB. What does IBB invest in? iShares Biotechnology ETF is a equity fund issued by iShares. IBB focuses on health care investments and follows the ICE Biotechnology Index (TR) (USD). The fund's investments total to approximately $7.08 billion assets under management. What stocks does iShares Biotechnology ETF hold? IBB invests in 223 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), Moderna (MRNA), IQVIA (IQV), Biogen (BIIB), Mettler-Toledo International (MTD), argenx (ARGX) and Illumina (ILMN). What is the management fee for iShares Biotechnology ETF? iShares Biotechnology ETF's management fee is 0.44% and has no other recorded expenses or fee waivers. The net expense ratio for IBB is 0.44%. When did iShares Biotechnology ETF's stock split? iShares Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL). Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BNP Paribas Financial Markets (3.70%), Commerce Bank (1.31%), Global Assets Advisory LLC (0.87%), Commonwealth Equity Services LLC (0.36%), Raymond James & Associates (0.33%) and Raymond James Financial Services Advisors Inc. (0.31%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IBB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.